We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Supplemental Calcium and Risk Reduction of Hypertension, Pregnancy-Induced Hypertension, and Preeclampsia: An Evidence-Based Review by the US Food and Drug Administration.
- Authors
Trumbo, Paula R.; Ellwood, Kathleen C.
- Abstract
The labeling of health claims that meet the significant scientific agreement (SSA) standard (authorized health claims) and qualified health claims on conventional foods and dietary supplements requires premarket approval by the US Food and Drug Administration (FDA). FDA conducts an evidence-based review to determine whether there is sufficient evidence to support an authorized or qualified health claim. An evidence-based review was conducted on the human intervention and observational studies evaluating the role of supplemental calcium in reducing the risk of hypertension, pregnancy-induced hypertension, and preeclampsia. This review provides FDA's evaluation of the current scientific evidence on the role of supplemental calcium in reducing the risk of these three end points. Based on this evidence-based review, the agency concluded that the relationship between calcium and risk of hypertension is inconsistent and inconclusive, and the relationship between calcium and risk of pregnancy-induced hypertension and preeclampsia is highly unlikely.
- Subjects
DIETARY supplements; UNITED States. Food &; Drug Administration; CALCIUM; VITAMIN research; CARDIOVASCULAR disease prevention; HYPERTENSION; PREECLAMPSIA prevention; PREGNANCY complications
- Publication
Nutrition Reviews, 2007, Vol 65, Issue 2, p78
- ISSN
0029-6643
- Publication type
Article